The National Cancer Institute of the National Institutes of Health will hold a session tomorrow, it said, “to discuss” new developments in nanotechnology in cancer. It will be held from 12:15-1:30 p.m. (PDT) in La Jolla, California, at the Marina del Rey Room of the San Diego Marriott in La Jolla. The session will include a review of nanotechnology, how it is affecting research, and accelerating the development of new diagnostics and therapies.
Speakers will include NCI leadership, as well as biologists, engineers and physicians who are members of the NCI Alliance for Nanotechnology in Cancer , an initiative to accelerate the application of nanotechnology to cancer research and patient care.
The speakers and topics:
Anna Barker, PhD, of the NCI Alliance for Nanotechnology in Cancer: “Catalyst for Transformation;” Thomas Kalil of the University of California (Berkeley): “Nanotechnology Policy Development: Regional and National Initiatives;” Sanjiv Gambhir, MD, PhD, of Stanford University (Stanford, California): “Molecular Imaging in Living Subjects: Shining a New Light on Cancer Diagnostics;” Sadik Esener, PhD of the University of California (San Diego): “Multi-compartment Delivery Vehicles: Novel Approaches for Targeted Therapies — Delivery Vehicles in Targeted Therapies: All Aboard the ‘Motherships;’” James Heath, PhD, of the California Institute of Technology (Pasadena): “Detecting the Impossible: Cancer Candidate Biomarkers and Capture Agents;” and Scott McNeil, PhD, of NCI: “Preclinical Characterization of Nanoparticles Intended for Medical Applications.”